Development of a high-performance-liquid-chromatographic method for the determination of biapigenin in biorelevant media

Journal of Pharmaceutical and Biomedical Analysis

Volumn 33, Issue 1, 2003, Pages 53-60

  Schulte Lobbert S ^a   Westerhoff, K ^a   Wilke, A ^a   Schubert Zsilavecz, M ^a   Wurglics, M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Biapigenin; Dissolution; FaSSIF; FeSSIF; Hypericum perforatum; SGFsp; St. John's Wort

Indexed keywords

ACETIC ACID; ACETONITRILE; BIAPIGENIN; HYPERICUM PERFORATUM EXTRACT; LAIF; METHANOL; PEPSIN A; SOLVENT; TEXX; UNCLASSIFIED DRUG;

ARTICLE; CAT; COMPARATIVE STUDY; DEVICE; DISSOLUTION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG RELEASE; DRUG SOLUBILITY; ELUTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; SIMULATION; SOLVENT EFFECT; STOMACH JUICE;

EID: 0142124319     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(03)00263-2     Document Type: Article

References (22)

1. Kasper S. Pharmacopsychiatry. 34:2001;51-55.
2. Nahrstedt A., Butterweck V. Pharmacopsychiatry. 30:(Suppl. 2):1997;129-134.
3. Berghöfer R., Hölzl J. Planta Med. 53:1987;216-217.
4. Tekel'ová D., Repcák M., Zemková E., Tótt J. Planta Med. 66:2000;778-780.
5. Simmen U., Higelin J., Berger-Büter K., Schaffner W., Lundstrom K. Pharmacopsychiatry. 34:(Suppl. 1):2001;S137-S142.
6. Wonnemann M. Pharmacopsychiatry. 34:(Suppl. 1):2001;S148-S151.
7. Scott Obach R. J. Pharmacol. Exp. Ther. 294:2000;88-95.
8. Gobbi M., Moia M., Pirona L., Morazzoni P., Mennini T. Pharmacopsychiatry. 34:2001;45-48.
9. M. Nöldner, Therapieforum Biozentrum, 2001.
10. Nöldner M. Planta Med. 68:(7):2002;577-580.
11. Westerhoff K. Dtsch. Apoth. Ztg. 10:2002;1153-1175.
12. Hölzl J., Ostrowski E. Dtsch. Apoth. Ztg. 127:(23):1987;1227-1230.
13. von Eggelkraut-Gottanka S.G., Abu Abed S., Müller W., Schmidt P.C. Phytochem. Anal. 13:2002;170-176.
14. Ganzera M., Zhao J., Khan I.A. J. Pharm. Sci. 91:(3):2001;623-630.
15. Galia E., Nicolaides E., Hörter D., Löbenberg R., Reppas C., Dressman J.B. Pharm. Res. 15:(5):1998;698-705.
16. CPMP/ICH/281/95: Note for Guidance on Validation of Analytical Procedures: Methodology.
17. Westerhoff K., Wurglics M., Kaunzinger A., Dressman J.B., Schubert-Zsilavecz M. Dtsch. Apoth. Ztg. 142:2002;203-207.
18. Biopharmaceutical Characterization of Herbal Medicinal Products, Pharm. Ind. 63 (10) (2001) 1005-1010.
19. Wurglics M., Westerhoff K., Kaunzinger A., Wilke A., Baumeister A., Dressman J.B., Schubert-Zsilavecz M. Pharmacopsychiatry. 34:2001;152-156.
20. Note for Guidance on specifications: test procedures and acceptance criteria for herbal drugs, herbal drug preparations and herbal medicinal products. CPMP/QWP/2820/00.
21. Westerhoff K., Kaunzinger A., Wurglics M., Dressman J.B., Schubert-Zsilavecz M. J. Pharm. Pharmacol. 54:2002;1-6.
22. Blume H., Brauer K.G., Dingermann T., Mutschler E., Zündorf I. Dtsch. Apoth. Ztg. 142:(10):2002;1205-1214.